Non-teratogenicity of antituberculous drugs.
D000014:Abnormalities, Drug-Induced; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004357:Drug Synergism; D005000:Ethionamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007538:Isoniazid / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D013307:Streptomycin / Q000627:therapeutic use; D013792:Thalidomide / Q000009:adverse effects; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D013792:Thalidomide; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin